Pancreatic Cancer

Nutritional Oncology, Second Edition

Volumn , Issue , 2006, Pages 449-473

  Harris, Diane M ^a   Champaneria, Manish C ^b   Go, Vay Liang W ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79959821641     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088393-6/50081-6     Document Type: Chapter

References (251)

1. E. Albrechtsson, T. Jonsson, S. Moller, M. Hogludn, B. Ohlsson and J. Axelson (2003) Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D 3 analogue decreases cell number. Pancreatology 3 41-46.
2. E. Albrechtsson, B. Ohlsson and J. Axelson (2002) The expression of retinoic acid receptors and the effets in vitro by retinoids in human pancreatic cancer cell lines. Pancreas 25 49-56.
3. American Cancer Society (2004) Cancer Facts and Figures 2004 Atlanta, GA: American Cancer Society
4. K.E. Anderson, R. Sinha, M. Kulldorff, M. Gross, N.P. Lang, C. Barber, L. Harnack, E. DiMagno, R. Bliss and F.F. Kadlubar (2002) Meat intake and cooking techniques: associations with pancreatic cancer. Mutat Res 506–507 225-231.
5. C.D. Andry, H.Z. Kupchik and A.E. Rogers (1990) L-azaserine induced preneoplasia in the rat pancreas. A morphometric study of dietary manipulation (lipotrope deficiency) and ultrastructural differentiation. Toxicol Pathol 18 10-17.
6. M.J. Appel, A. Garderen-Hoetmer and R.A. Woutersen (1996) Lack of inhibitory effects of β-carotene, vitamin C, vitamin E and selenium on development of ductular adeocarcinomas in exocrine pancreas of hamsters. Cancer Lett 103 157-162.
7. M.J. Appel and R.A. Woutersen (1994) Modlaton of growth and cell turnover of preneoplastic lesions and of prostaglandin levels in rat pancreas by dietary fish oil. Carcinogenesis 15 2107-2112.
8. M.J. Appel and R.A. Woutersen (1995) Effects of dietary fish oil (MaxEPA) on N-nitrosobis(2-oxopropyl)amine (BOP)—induced pancreatic carcinogenesis in hamsters. Cancer Lett 94 179-189.
9. M.J. Appel and R.A. Woutersen (1996) Dietary fish oil (MaxEPA) enhances panreatic arcinogenesis in azaserine-treated rats. Br J Cancer 73 36-43.
10. M.J. Appel and R.A. Woutersen (1996) Effects of dietary β-carotene and selenium on initiation and promotion of pancreatic carcinogenesis in azaserine-treated rats. Carcinogenesis 17 1411-1416.
11. L.S. Augustin, S. Franceschi, D.J. Jenkins, C.W. Kendall and V.C. La (2002) Glycemic index in chronic disease: a review. Eur J Clin Nutr 56 1049-1071.
12. P.A. Baghurst, A.J. McMichael, A.H. Slavotinek, K.I. Baghurst, P. Boyle and A.M. Walker (1991) A case-control study of diet and cancer of the pancreas. Am J Epidemiol 134 167-179.
13. M.D. Barber, K.C. Fearon, M.J. Tisdale, D.C. McMillan and J.A. Ross (2001) Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer 40 118-124.
14. M.D. Barber, J.A. Ross, A.C. Voss, M.J. Tisdale and K.C. Fearon (1999) The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 81 80-86.
15. N. Bardeesy and R.A. DePinho (2002) Pancreatic cancer biology and genetics. Nat Rev Cancer 2 897-909.
16. R.H. Bell Jr, P.J. McCullough and P.M. Pour (1988) Influence of diabetes on susceptibility to experimental pancreatic cancer. Am J Surg 155 159-164.
17. R.H. Bell Jr., H.J. Sayers, P.M. Pour, M.B. Ray and P.J. McCullough (1989) Importance of diabetes in inhibition of pancreatic cancer by streptozotocin. J Surg Res 46 515-519.
18. I.F. Bezie (2000) Evolution of antioxidant defence mechanisms. Eur J Nutr 39 53-61.
19. U. Bergmann, H. Funatomi, M. Yokoyama, H.G. Beger and M. Korc (1995) Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55 2007-2011.
20. A. Berrington de Gonzalez, S. Sweetland and E. Spenceer (2003) A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89 519-523.
21. D.F. Brit, M.H. Davies, P.M. Pour and S. Salmasi (1983) Lack of inhibition by retinoids of bis(2-oxopropyl)nitrosamine-induced carcinogenesis in Syrian hamsters. Carcinogenesis 4 1215-1220.
22. D.F. Birt, P.M. Pour, D.L. Nagel, T. Barnett, D. Blackwood and E. Duysen (1997) Dietary energy restriction does not inhibit pancreatic carcino-genesis by N-nitrosobis-2-(oxopropyl)amine in the Syrian hamster. Carcinogenesis 18 2107-2111.
23. D.F. Birt, S. Sayed, M.H. Davies and P. Pour (1981) Sex differences in the effects of retinoids on carcinogenesis by N-nitrosobis(2-oxopropyl)amine in Syrian hamsters. Cancer Lett 14 13-21.
24. D. Bisachi, R. Benelli, C. Vanzetto, N. Ferrari, F. Tosetti and A. Albini (2003) Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev 27 229-238.
25. G. Block, B. Patterson and A. Subar (1992) Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer 18 1-29.
26. R.J. Bold, J. Ishizuka, C.M. Townsend Jr. and J.C. Thompson (1996) All- trans-retinoic acid inhibits growth of human pancreatic cancer cell lines. Pancreas 12 189-195.
27. C.W. Boone and G.J. Kelloff (2004) Cancer chemoprevention: subject cohorts with early neoplasia, agents, and intermediate marker endpoints in clinical trials evaluated by computer-assisted image analysis. D. Heber, G.L. Blackburn, V.L. Go (Eds) Nutritional Oncology Vol. 22 San Diego: Academic Press 343-378.
28. L.G. Boros, S. Bassilian, S. Lim and W.N. Lee (2001) Genistein inhibits nonoxidative ribose synthesis in MIA pancreatic adenocarcinoma cells: a new mechanism of controlling tumor growth. Pancreas 22 1-7.
29. L.G. Boros, W.N. Lee and V.L. Go (2002) A metabolic hypothesis of cell growth and death in pancreatic cancer. Pancreas 24 26-33.
30. L.G. Boros, J.S. Torday, S. Lim, S. Bassilian, M. Cascante and W.N. Lee (2000) Transforming growth factor β 2 promotes glucose carbon incorporation into nucleic acid ribose through the nonoxidative pentose cycle in lung epithelial carcinoma cells. Cancer Res 60 1183-1185.
31. F.H. Brembeck, K. Schoppmeyer, U. Leupold, C. Gornistu, V. Keim, J. Mossner, E.O. Riecken and S. Rosewicz (1998) A phase II pilot trial of 13- cis retinotic acid and interferon-α in patients with advanced pancreatic carcinoma. Cancer 83 2317-2323.
32. P. Bremner and M. Heinrich (2002) Natural products as targeted modulators of the nuclear factor-κB pathway. J Pharm Pharmacol 54 453-472.
33. P. Buchler, A.S. Gukovskaya, M. Mouria, M.C. Buchler, M.W. Buchler, H. Friess, S.J. Pandol, H.A. Reber and O.J. Hines (2003) Prevention of metastatic pancreatic cancer growth in vivo by induction of apoptosis with genistein, a naturally occurring isoflavonoid. Pancreas 26 264-273.
34. Y.D. Burke, A.S. Ayoubi, S.R. Werner, B.C. McFarland, D.K. Heilman, B.A. Ruggeri and P.L. Crowell (2002) Effects of the isoprenoids perillyl alcohol and farnesol on apoptosis biomarkers in pancreatic cancer chemoprevention. Anticancer Res 22 3127-3134.
35. Y.D. Burke, M.J. Stark, S.L. Roach, S.E. Sen and P.L. Crowell (1997) Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol. Lipids 32 151-156.
36. J.L. Bushman (1998) Green tea and cancer in humans: a review of the literature. Nutr Cancer 31 151-159.
37. C. Caldas (1999) Biliopancreic malignancy: screening the at risk patient with molecular markers. Ann Oncol 10(Suppl 4), 153-156.
38. E.E. Calle and R. Kaaks (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4 579-591.
39. E.E. Calle, C. Rodriguez, K. Walker-Thurmond and M.J. Thun (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348 1625-1638.
40. A. Choudhury, R.K. Singh, N. Moniaux, T.H. El-Metwally, J.P. Aubert and S.K. Batra (2000) Retinoic acid-dependent transforming growth factor-β 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-α signaling pathway. J Biol Chem 275 33929-33936.
41. K.W. Colston, S.Y. James, E.A. Ofori-Kuragu, L. Binderup and A.G. Grant (1997) Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer 76 1017-1020.
42. J.J. Cullen, F.A. Mitros and L.W. Oberley (2003) Expression of antioxidant enzymes in diseases of the human pancreas: another link between chronic pancreatitis and pancreatic cancer. Pancreas 26 23-27.
43. J.J. Cullen, C. Weyder, M.M. Hinkhouse, J. Ritchie, F.E. Domann, D. Spitz and L.W. Oberley (2003) The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res 63 1297-1303.
44. T.J. Curphey, E.T. Kuhlman, B.D. Roebuck and D.S. Longnecker (1988) Inhibition of pancreatic and liver carcinogenesis in rats by retinoid-and selenium-supplemented diets. Pancreas 3 36-40.
45. X.Z. Ding and T.E. Adrian (2002) Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Pancreas 25 e71-e76.
46. X.Z. Ding, C.A. Kuszynski, T.H. El-Metwally and T.E. Adrian (1999) Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells. Biochem Biophys Res Commun 266 392-399.
47. E.J. Duell, E.A. Holly, P.M. Bracci, J.K. Wiencke and K.T. Kelsey (2002) A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 62 4630-4636.
48. M.C. Dufour and M.D. Adamson (2003) The epidemiology of alcohol-induced pancreatitis. Pancreas 27 286-290.
49. J.P. Durbec and H. Sarles (1978) Multicenter survey of the etiology of pancreatic diseases. Relationship between the relative risk of developing chronic pancreaitis and alcohol, protein and lipid consumption. Digestion 18 337-350.
50. G. Eibl, H.A. Reber, O.J. Hines and V.L. Go (2004) COX and PPAR: possible interactions in pancreatic cancer. Pancreas 29 247-253.
51. G. Eibl, M.N. Wente, H.A. Reber and O.J. Hines (2001) Peroxisome proliferator-activated receptor-γ induces pancreatic cancer cell apoptosis. Biochem Biophys Res Commun 287 522-529.
52. T.H. El-Metwally, M.R. Hussein, P.M. Pour, C.A. Kuszynski and T.E. Adrian (2005) Natural retinoids inhibit proliferation and induce apoptosis in pancreatic cancer cells previously reported to be retinoid resistant. Cancer Biol Ther 4 474-483.
53. T.H. El-Metwally, M.R. Hussein, P.M. Pour, C.A. Kuszynski and T.E. Adrian (2005) High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro. Cancer Biol Ther 4 602-611.
54. T.R. Evans, K.W. Colston, F.J. Lofts, D. Cunningham, D.A. Anthoney, H. Gogas, J.S. de Bono, K.J. Hamberg, T. Skov and J.L. Mansi (2002) A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer. Br J Cancer 86 680-685.
55. J. Everhart and D. Wright (1995) Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273 1605-1609.
56. B. Farrow and B.M. Evers (2002) Inflammation and the development of pancreatic cancer. Surg. Oncol. 10 153-169.
57. B. Farrow, K.L. O'Connor, K. Hashimoto, T. Iwamura and B.M. Evers (2003) Selective activation of PPARg inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator. Surgery 134 206-312.
58. L.R. Ferguson (2001) Role of plant polyphenols in genomic stability. Mutat Res 475 89-111.
59. W.E. Fisher, L.G. Boros and W.J. Schirmer (1996) Insulin promotes pancreatic cancer: evidence for endocrine influence on exocrine pancreatic tumors. J Surg Res 63 310-313.
60. B.B. Flossmann-Kast, P.M. Jehle, A. Hoeflich, G. Adler and M.P. Lutz (1998) Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res 58 3551-3554.
61. F. Furukawa, A. Nishikawa, I.S. Lee, K. Kanki, T. Umemura, K. Okazaki, T. Kawamori, K. Wakabayashi and M. Hirose (2003) A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine—induced pancreatic carciogenesis in hamsters. Int J Cancer 104 269-273.
62. F. Furukawa, A. Nishikawa, I.S. Lee, H.Y. Son, H. Nakamura, M. Miyauchi, M. Takahashi and M. Hirose (2000) Inhibition by methionine of pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl) amine. Cancer Lett 152 163-167.
63. S.M. Gapstur, P.H. Gann, W. Lowe, K. Liu, L. Colangelo and A. Dyer (2000) Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283 2552-2558.
64. J.B. German, D.E. Bauman, D.G. Burrin, M.L. Failla, H.C. Freake, J.C. King, S. Klein, J.A. Milner, G.H. Pelto, K.M. Rasmussen and S.H. Zeisel (2004) Metabolomics in the opening decade of the 21st century: building the roads to individualized health. J Nutr 134 2729-2732.
65. P. Ghadirian, H.T. Lynch and D. Krewski (2003) Epidemiology of pancreatic cancer: an overview. Cancer Detect Prev 27 87-93.
66. P. Ghadirian, A. Simard, J. Baillargeon, P. Maisonneve and P. Boyle (1991) Nutritional factors and pancreatic cancer in the Francophone community in Montreal, Canada. Int J Cancer 47 1-6.
67. P. Ghadirian, J.P. Thouez and C. PetitClerc (1991) International comparisons of nutrition and mortality from pancreatic cancer. Cancer Detect prev 15 357-362.
68. V.L. Go, R.R. Butrum and D.A. Wong (2003) Diet, nutrition, and cancer prevention: the postgenomic era. J Nutr 133 3830S-3836S.
69. V.L. Go, C.T. Nguyen, D.M. Harris and W.N. Lee (2005) Nutrient—gene interaction: Metabolic genotype-phenotype relationship. J Nutr 135 3016S-3020S.
70. V.L. Go, D.A. Wong and R. Butrum (2001) Diet, nutrition and cancer prevention: where are we going from here? J Nutr 131 3121S-3126S.
71. V. Go, A. Gukovskaya and S. Pandol (2005) Alcohol and pancreatic cancer. Alcohol 35 205-211.
72. V. Go and Y. Wang (2005) Pancreatic exocrine-endocrine interactions. P.M. Pour (Eds) Toxicology of the Pancreas London, U.K.: Taylor and Francis Books Ltd
73. M. Goggins (2005) Molecular markers of early pancreatic cancer. J Clin Oncol 23 4524-4531.
74. E.B. Gold (1995) Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 75 819-843.
75. L. Gordis and E.B. Gold (1984) Epidemiology of pancreatic cancer. World J Surg 8 808-821.
76. I. Gukovsky, C.N. Reyes, E.C. Vaquero, A.S. Gukovskaya and S.J. Pandol (2003) Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 284 G85-G95.
77. D. Hanahan and R.A. Weinberg (2000) The hallmarks of cancer. Cell 100 57-70.
78. A.J. Hanley, K.C. Johnson, P.J. Villeneuve and Y. Mao (2001) Physical activity, anthropometric factors and risk of pancreatic cancer: results from the Canadian enhanced cancer surveillance system. Int J Cancer 94 140-147.
79. D.E. Hansel, S.E. Kern and R.H. Hruban (2003) Molecular pathogenesis of pancreatic cancer. Annu Rev Genomics Hum Genet 4 237-256.
80. L.J. Harnack, K.E. Anderson, W. Zheng, A.R. Folsom, T.A. Sellers and L.H. Kushi (1997) Smoking, alcohol coffee, and tea intake and incidence of cancer of the exocrine pancreas: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 6 1081-1086.
81. A.R. Hart (1999) Pancreatic cancer: any prospects for prevention? Postgrad Med J 75 521-526.
82. K. Hashimoto, R.T. Ethridge and B.M. Evers (2002) Peroxisome proliferator-activated receptor-g ligand inhibits cell growth and invasion of human pancreatic cancer cells. Int J Gastrointest Cancer 32 7-22.
83. D. Heber and Q.Y. Lu (2002) Overview of mechanisms of action of lycopene. Exp Biol Med Maywood 227 920-923.
84. R. Hennig, X.Z. Ding, W.G. Tong, M.B. Schneider, J. Standop, H. Friess, M.W. Buchler, P.M. Pour and T.E. Adrian (2002) 5-Lipoxygenase and leukotriene B 4 recepotr are expressed in human pancreatic cancers but not in pancreatic ducts in normal tissue. Am J Pathol 161 421-428.
85. I. Heuch, G. Kvale, B.K. Jacobsen and E. Bjelke (1983) Use of alcohol, tobacco and coffee, and risk of pancreatic cancer. Br J Cancer 48 637-643.
86. H. Hidaka, T. Ishiko, T. Furuhashi, H. Kamohara, S. Suzuki, M. Miyazaki, O. Ikeda, S. Mita, T. Setoguchi and M. Ogawa (2002) Curcumin inhibits interleukin-8 production and enhances interleukin 8 receptor expression on the cell surface: Impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95 1206-1214.
87. R.J. Hine, S. Srivastava, J.A. Milner and S.A. Ross (2003) Nutritional links to plausible mechanisms underlying pancreatic cancer: a conference report Pancreas 27 356-366.
88. S.R. Hingorani, E.F. Petricoin, A. Maitra, V. Rajapakse, C. King, M.A. Jacobetz, S. Ross, T.P. Conrads, T.D. Veenstra, B.A. Hitt, Y. Kawaguchi, D. Johann, L.A. Liotta, H.C. Crawford, M.E. Putt, T. Jacks, C.V. Wright, R.H. Hruban, A.M. Lowy and D.A. Tuveson (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4 437-450.
89. A. Hiura, M. Tsutsumi and K. Satake (1997) Inhibitory effect of green tea extract on the process of pancreatic carcinogenesis induced by N-nitrosobis-(2-oxypropyl)amine (BOP) and on tumor promotion after transplantation of N-nitrosobis-(2-hydroxypropyl)amine (BHP)-induced pancreatic cancer in Syrian hamsters. Pancreas 15 272-277.
90. H.G. Hotz, O.J. Hines, T. Foitzik and H.A. Reber (2000) Animal models of exocrine pancreatic cancer. Int J Colorectal Dis 15 136-143.
91. H.G. Hotz, H.A. Reber, B. Hotz, T. Yu, T. Foitzik, H.J. Buhr, G. Cortina and O.J. Hines (2003) An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 26 e89-e98.
92. G.R. Howe and J.D. Burch (1996) Nutrition and pancreatic cancer. Cancer Causes Control 7 69-82.
93. G.R. Howe, P. Ghadirian, H.B. Bueno de Mesquita, W.A. Zatonski, P.A. Baghurst, A.B. Miller, A. Simard, J. Baillargeon, F. de Waard, K. Przewozniak, A.J. McMichael, M. Jain, C.C. Hsteh, P. Maisonneure, P. Boyle and A.M. Walker (1992) A collaborative case-control study of nutrient intake and pancreatic cancer within the SEARCH programme. Int J Cancer 51 365-372.
94. R.H. Hruban, G.M. Petersen, M. Goggins, A.C. Tersmette, G.J. Offerhaus, F. Falatko, C.J. Yeo and S.E. Kern (1999) Familial pancreatic cancer. Ann Oncol 10(Suppl 4), 69-73.
95. R. Huxley, A. Ansary-Moghaddam, G.A. Berrington de, F. Barzi and M. Woodward (2005) Type-II diabetes and pancreatic cancer: a metaanalysis of 36 studies. Br J Cancer 92 2076-2083.
96. C.A. Iacobuzio-Donahue and R.H. Hruban (2003) Gene expression in neoplasms of the pancreas: applications to diagnotic pathology. Adv Anat Pathol 10 125-134.
97. IARC Working Group on the Evaluation of Cancer-Preventive Strategies (2003) H. Vainio, F. Bianchini (Eds) “Fruits and Vegetables” IARC Handbooks of Cancer Prevention Vol. 8 Lyon, France: IARC Press
98. B. Isaksson, F. Jonsson, N.L. Pedersen, J. Larsson, M. Feychting and J. Permert (2002) Lifestyle factors and pancreatic cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer 98 480-482.
99. A. Itami, G. Watanabe, Y. Shimada, Y. Hashimoto, J. Kawamura, M. Kato, R. Hosotani and M. Imamura (2001) Ligands for peroxisome proliferator-activated receptor γ inhibit growth of pancreatic cancers both in vitro and in vivo. Int J Cancer 94 370-376.
100. R. Jaenisch and A. Bird (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl), 245-254.
101. E.M. Jaffee, R.H. Hruban, M. Canto and S.E. Kern (2002) Focus on pancreas cancer. Cancer Cell 2 25-28.
102. B.T. Ji, W.H. Chow, A.W. Hsing, J.K. Mclaughlin, Q. Dai, Y.T. Gao, W.J. Blot and J.F. Fraumeni Jr. (1997) Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 70 255-258.
103. A. Kaiser, F.H. Brembeck, B. Nicke, B. Wiedenmann, E.O. Riecken and S. Rosewicz (1999) All- trans-retinoic acid-mediated growth inhibition involves inhibition of human kinesin-related protein HsEg5. J Biol Chem 274 18925-18931.
104. S. Kawa, T. Nikaido, Y. Aoki, Y. Zhai, T. Kumagai, K. Furihata, S. Fujii and K. Kiyosawa (1997) Vitamin D analogues up-regulate p21 and p27 during growth inhibition of pancreatic cancer cell lines. Br J Cancer 76 884-889.
105. S. Kawa, T. Nikaido, H. Unno, N. Usuda, K. Nakayama and K. Kiyosawa (2002) Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR-γ ligand troglitazone. Pancreas 24 1-7.
106. S. Kawa, K. Yoshizawa, M. Tokoo, H. Imai, H. Oguchi, K. Kiyosawa, T. Homma, T. Nikaido and K. Furihata (1996) Inhibitory effect of 22-oxa-1,25-dihydroxyvitamin D 3 on the proliferation of pancreatic cancer cell lines. Gastroenterology 110 1605-1613.
107. K. Kazakoff, T. Cardesa, J. Liu, T.E. Adrian, D. Bagchi, M. Bagchi, D.F. Birt and P.M. Pour (1996) Effects of voluntary physical exercise, on high-fat diet-promoted pancreatic carcinogenesis in the hamster model. Nutr Cancer 26 265-279.
108. S. Kern, R. Hruban, M.A. Hollingsworth, R. Brand, T.E. Adrian, E. Jaffee and M.A. Tempero (2001) A white paper: the product of a pancreas cancer think tank. Cancer Res 61 4923-4932.
109. M. Kilian, I. Mautsch, J.I. Gregor, D. Heinichen, C.A. Jacobi, I. Schimke, H. Guski, J.M. Muller and F.A. Wenger (2003) Influence of conjugated and conventional linoleic acid on tumor growth and lipid peroxidation in pancreatic adenocarcinoma in hamster. Prostaglandins Leukot Essent Fatty Acids 69 67-72.
110. M. Kilian, I. Mautsch, J.I. Gregor, P. Stahlknecht, C.A. Jacobi, I. Schimke, H. Guski and F.A. Wenger (2002) Influence of conjugated vs. conventional linoleic acid on liver metastasis and hepatic lipidperoxidation in BOP-induced pancreatic cancer in Syrian hamster. Prostaglandins Leukot Essent Fatty Acids 67 223-228.
111. Y. Kise, M. Yamamura, M. Kogata, S. Uetsuji, H. Takada, K. Hioki and M. Yamamoto (1990) Inhibitory effect of selenium on hamster pancreatic cancer induction by N′-nitrosobis(2-oxopropyl)amine. Int J Cancer 46 95-100.
112. H. Kono, M. Nakagami, I. Rusyn, H.D. Connor, B. Stefanovic, D.A. Brenner, R.P. Mason, G.E. Arteel and R.G. Thurman (2001) Development of an animal model of chronic alcohol-induced pancreatitis in the rat. Am J Physiol Gastrointest Liver Physiol 280 G1178-G1186.
113. P.M. Kris-Etherton, K.D. Hecker, A. Bonanome, S.M. Coval, A.E. Binkoski, K.F. Hilpert, A.E. Griel and T.D. Etherton (2002) Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer. Am J Med 113(Suppl 9B), 71S-88S.
114. T. Kuroki, Y. Tajima and T. Kanematsu (2004) Role of hypermethylation on carcinogenesis in the pancreas. Surg Today 34 981-986.
115. S.D. Leach (2004) Mouse models of pancreatic cancer: the fur is finally flying. Cancer Cell 5 7-11.
116. I.M. Lee, H.D. Sesso, Y. Oguma and R.S. Paffenbarger Jr. (2003) Physical activity, body weight, and pancreatic cancer mortality. Br J Cancer 88 679-683.
117. K. Leelawat, K. Ohuchida, K. Mizumoto, C. Mahidol and M. Tanaka (2005) All- trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett 224 303-310.
118. D. Li, M. Ahmed, Y. Li, L. Jiao, T.H. Chou, R.A. Wolff, R. Lenzi, D.B. Evans, M.L. Bondy, P.W. Pisters, J.L. Abbruzzese and M.M. Hassan (2005) 5,10-Methylenetetrahydrofolate reductase polymorphisms and the risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 14 1470-1476.
119. D. Li and L. Jiao (2003) Molecular epidemiology of pancreatic cancer. Int J Gastrointest Cancer 33 3-14.
120. D. Li, K. Xie, R. Wolff and J.L. Abbruzzese (2004) Pancreatic cancer. Lancet 363 1049-1057.
121. L. Li, B.B. Aggarwal, S. Shishodia, J. Abbruzzese and R. Kurzrock (2004) Nuclear factor-ϰB and IϰB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101 2351-2362.
122. J.P. Lian, B. Word, S. Taylor, G.J. Hammons and B.D. Lyn-Cook (2004) Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. Anticancer Res 24 133-137.
123. C.S. Lieber (2000) Alcohol: its metabolism and interaction with nutrients. Annu Rev Nutr 20 395-430.
124. H.J. Lin, N.M. Probst-Hensch, A.D. Louie, I.H. Kau, J.S. Witte, S.A. Ingles, H.D. Frankl, E.R. Lee and R.W. Haile (1998) Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 7 647-652.
125. Y. Lin, A. Tamakoshi, T. Kawamura, Y. Inaba, S. Kikuchi, Y. Motohashi, M. Kurosawa and Y. Ohno (2002) Risk of pancreatic cancer in relation to alcohol drinking, coffee consumption and medical history: findings from the Japan collaborative cohort study for evaluation of cancer risk. Int J Cancer 99 742-746.
126. Y. Lin, A. Tamakoshi, S. Kikuchi, K. Yagyu, Y. Obata, T. Ishibashi, T. Kawamura, Y. Inaba, M. Kurosawa, Y. Motohashi and Y. Ohno (2004) Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 110 584-588.
127. S.M. Lippman and W.K. Hong (2002) Cancer prevention by delay. Commentary re: J.A. O'Shaughnessy et al., Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Clin Cancer Res 8 314-346.
128. S.M. Lippman and W.K. Hong (2002) Cancer prevention by delay. Commentary re: J.A. O'Shaughnessy et al., Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Clin Cancer Res 8 305-313.
129. D.S. Longnecker, N. Chandar, D.G. Sheahan, J.E. Janosky and B. Lombardi (1991) Preneoplastic and neoplastic lesions in the pancreas of rats fed choline-devoid or choline-supplemented diets. Toxicol Pathol 19 59-65.
130. D.S. Longnecker, T.J. Curphey, E.T. Kuhlmann and B.D. Roebuck (1982) Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats. Cancer Res 42 19-24.
131. D.S. Longnecker, T.J. Curphey, E.T. Kuhlmann, B.D. Roebuck and R.K. Neff (1986) Effects of retinoids in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Pancreas 1 224-231.
132. D.S. Longnecker, E.T. Kuhlmann and T.J. Curphey (1983) Effects of four retinoids in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Cancer Res 43 3226-3230.
133. A.B. Lowenfels, P. Maisonneuve, G. Cavallini, R.W. Ammann, P.G. Lankisch, J.R. Andersen, E.P. DiMagno, A. ndren-Sandberg and L. Domellof (1993) Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 328 1433-1437.
134. B.D. Lyn-Cook, T. Rogers, Y. Yan, E.B. Blann, F.F. Kadlubar and G.J. Hammons (1999) Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 35 80-86.
135. B.D. Lyn-Cook, H.L. Stottman, Y. Yan, E. Blann, F.F. Kadlubar and G.J. Hammons (1999) The effects of phytoestrogens on human pancreatic tumor cells in vitro. Cancer Lett 142 111-119.
136. T.M. Mack, M.C. Yu, R. Hanisch and B.E. Henderson (1986) Pancreas cancer and smoking, beverage consumption, and past medical history. J Natl Cancer Inst 76 49-60.
137. M.J. MacKenzie (2004) Molecular therapy in pancreatic adenocarcinoma. Lancet Oncol 5 541-549.
138. B. MacMahon, S. Yen, D. Trichopoulos, K. Warren and G. Nardi (1981) Coffee and cancer of the pancreas. N Engl J Med 304 630-633.
139. A. Maitra, N.V. Adsay, P. Argani, C. Iacobuzio-Donahue, A. De Marzo, J.L. Cameron, C.J. Yeo and R.H. Hruban (2003) Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16 902-912.
140. T. Majima, M. Tsutsumi, H. Nishino, T. Tsunoda and Y. Konishi (1998) Inhibitory effects of β-carotene, palm carotene, and green tea polyphenols on pancreatic carcinogenesis initiated by N-nitrosobis(2-oxopropyl)amine in Syrian golden hamsters. Pancreas 16 13-18.
141. M.F. McCarty (2001) Insulin secretion as a determinant of pancreatic cancer risk. Med Hypotheses 57 146-150.
142. D.S. Michaud (2004) Epidemiology of pancreatic cancer. Minerva Chir 59 99-111.
143. D.S. Michaud, E. Giovannucci, W.C. Willett, G.A. Colditz, M.J. Stampfer and C.S. Fuchs (2001) Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286 921-929.
144. D.S. Michaud, S. Liu, E. Giovannucci, W.C. Willett, G.A. Colditz and C.S. Fuchs (2002) Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study. J Natl Cancer Inst 94 1293-1300.
145. J.A. Milner (2002) Strategies for cancer prevention: the role of diet. Br J Nutr 87(Suppl 2), S265-S272.
146. J.A. Milner, S.S. McDonald, D.E. Anderson and P. Greenwald (2001) Molecular targets for nutrients involved with cancer prevention. Nutr Cancer 41 1-16.
147. H. Mo and C.E. Elson (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med (Maywood) 229 567-585.
148. D.F. Moore Jr., R. Pazdur, S. Sugarman, D. Jones III, S.M. Lippman, B. Bready and J.L. Abbruzzese (1995) Pilot phase II trial of 13- cis-retinoic acid and interferon-α combination therapy for advanced pancreatic adenocarcinoma. Am J Clin Oncol 18 525-527.
149. W. Motomura, M. Nagamine, S. Tanno, M. Sawamukai, N. Takahashi, Y. Kohgo and T. Okumura (2004) Inhibition of cell invasion and morphological change by troglitazone in human pancreatic cancer cells. J Gastroenterol 39 461-468.
150. W. Motomura, T. Okumura, N. Takahashi, T. Obara and Y. Kohgo (2000) Activation of peroxisome proliferator-activated receptor-γ by troglitazone inhibits cell growth through the increase of p27 KiPl in human pancreatic carcinoma cells. Cancer Res 60 5558-5564.
151. M. Mouria, A.S. Gukovskaya, Y. Jung, P. Buechler, O.J. Hines, H.A. Reber and S.J. Pandol (2002) Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome C release and apoptosis. Int J Cancer 98 761-769.
152. C. Muller, A.G. Bockhorn, S. Klusmeier, M. Kiehl, C. Roeder, H. Kalthoff and O.M. Koch (1998) Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogen but has different effects on protein phosphorylation and induction of apoptosis. Int J Oncol 12 717-723.
153. P.N. Nair, D.T. De Armond, M.L. Adamo, W.E. Strodel and J.W. Freeman (2001) Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Oncogene 20 8203-8214.
154. R.M. Niles (2004) Signaling pathways in retinoid chemoprevention and treatment of cancer. Mutat Res 555 81-96.
155. A. Nishikawa, F. Furukawa, K. Kasahara, Z. Tanakamaru, M. Miyauchi, H. Nakamura, T. Ikeda, T. Imazawa and M. Hirose (1999) Failure of phenethyl isothiocyanate to inhibit hamster tumorigenesis induced by N-nitrosobis(2-oxopropyl)amine when given during the post-initiation phase. Cancer Lett 141 109-115.
156. A. Nishikawa, F. Furukawa, I.S. Lee, T. Tanaka and M. Hirose (2004) Potent chemopreventive agents against pancreatic cancer. Curr Cancer Drug Targets 4 373-384.
157. A. Nishikawa, F. Furukawa, C. Uneyama, S. Ikezaki, Z. Tanakamaru, F.L. Chung, M. Takahashi and Y. Hayashi (1996) Chemopreventive effects of phenethyl isothiocyanate on lung and pancreatic tumorigenesis in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Carcinogenesis 17 1381-1384.
158. A. Nishikawa, I.S. Lee, C. Uneyama, F. Furukawa, H.C. Kim, K. Kasahara, N. Huh and M. Takahashi (1997) Mechanistic insights into chemopreventive effects of phenethyl isothiocyanate in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Jpn J Cancer Res 88 1137-1142.
159. A. Nkondjock, P. Ghadirian, K.C. Johnson and D. Krewski (2005) Dietary intake of lycopene is associated with reduced pancreatic cancer risk. J Nutr 135 592-597.
160. A. Nkondjock, D. Krewski, K.C. Johnson and P. Ghadirian (2005) Dietary patterns and risk of pancreatic cancer. Int J Cancer 114 817-823.
161. F. Nozawa, A. Itami, M. Saruc, M. Kim, J. Standop, K.S. Picha, K.H. Cowan and P.M. Pour (2004) The combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL/Apo2L), and genistein is effective in inhibiting pancreatic cancer growth. Pancreas 29 45-52.
162. T.P. O'Connor, B.D. Roebuck, F. Peterson and T.C. Campbell (1985) Effect of dietary intake of fish oil and fish protein on the development of L-azaserine-induced preneoplastic lesions in the rat pancreas. J Natl Cancer Inst 75 959-962.
163. T.P. O'Connor, B.D. Roebuck, F.J. Peterson, B. Lokesh, J.E. Kinsella and T.C. Campbell (1989) Effect of dietary omega-3 and omega-6 fatty acids on development of azaserine-induced preneoplastic lesions in rat pancreas. J Natl Cancer Inst 81 858-863.
164. S. O'Mahony and A. Sreedharan (2001) Does detection of K-ras mutations in pancreatic juice influence clinical decision making? Eur J Gastroenterol Hepatol 13 1141-1142.
165. S. Ohba, M. Nishi and H. Miyake (1996) Eating habits and pancreas cancer. Int J Pancreatol 20 37-42.
166. B. Ohlsson, E. Albrechtsson and J. Axelson (2004) Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines. Scand J Gastroenterol 39 882-885.
167. E. Ohmura, M. Okada, N. Onoda, Y. Kamiya, H. Murakami, T. Tsushima and K. Shizume (1990) Insulin-like growth factor I and transforming growth factor-α as autocrine growth factors in human pancreatic cancer cell growth. Cancer Res 50 103-107.
168. T. Ohta, A. Elnemr, M. Yamamoto, I. Ninomiya, S. Fushida, G. Nishimura, T. Fujimura, H. Kitagawa, M. Kayahara, K. Shimizu, S. Yi and K. Miwa (2002) Thiazolidinedione, a peroxisome proliferator-activated receptor-γ ligand, modulates the E-cadherin/β-catenin system in a human pancreatic cancer cell line, BxPC-3. Int J Oncol 21 37-42.
169. H. Ozcelik, B. Schmocker, N.N. Di, X.H. Shi, B. Langer, M. Moore, B.R. Taylor, S.A. Narod, G. Darlington, I.L. Andrulis, S. Gallinger and M. Redston (1997) Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet 16 17-18.
170. A.V. Patel, C. Rodriguez, L. Bernstein, A. Chao, M.J. Thun and E.E. Calle (2005) Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort. Cancer Epidemiol Biomarkers Prev 14 459-466.
171. G. Peterson and S. Barnes (1996) Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 7 1345-1351.
172. F. Pettersson, K.W. Colston and A.G. Dalgleish (2000) Differential and antagonistic effects of 9- cis-retinoic acid and vitamin D analogues on pancreatic cancer, cells in vitro. Br J Cancer 83 239-245.
173. F. Pettersson, A.G. Dalgleish, R.P. Bissonnette and K.W. Colston (2002) Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-γ and altered expression of Bcl-2/Bax. Br J Cancer 87 555-561.
174. N.A. Pham, J.W. Jacobberger, A.D. Schimmer, P. Cao, M. Gronda and D.W. Hedley (2004) The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther 3 1239-1248.
175. M. Porta, N. Malats, J. Alguacil, L. Ruiz, M. Jariod, A. Carrato, J. Rifa and L. Guarner (2000) Coffee, pancreatic cancer, and K-ras mutations: updating the research agenda. J Epidemiol Community Health 54 656-659.
176. M. Porta, N. Malats, L. Guarner, A. Carrato, J. Rifa, A. Salas, J.M. Corominas, M. Andreu and F.X. Real (1999) Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group. J Epidemiol Community Health 53 702-709.
177. E.M. Posadas, F. Simpkins, L.A. Liotta, C. MacDonald and E.C. Kohn (2005) Proteomic analysis for the early detection and rational treatment of cancer—realistic hope? Ann Oncol 16 16-22.
178. G. Poschl and H.K. Seitz (2004) Alcohol and cancer. Alcohol Alcohol 39 155-165.
179. S. Qanungo, M. Das, S. Haldar and A. Basu (2005) Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells. Carcinogenesis 26 958-967.
180. M.T. Rautalahti, J.R. Virtamo, P.R. Taylor, O.P. Heinonen, D. Albanes, J.K. Haukka, B.K. Edwards, P.A. Karkkainen, R.Z. Stolzenberg-Solomon and J. Huttunen (1999) The effects of supplementation with α-tocopherol and β-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer 86 37-42.
181. F. Recchia, G. Sica, D. Casucci, S. Rea, A. Gulino and L. Frati (1998) Advanced carcinoma of the pancreas: phase II study of combined chemotherapy, β-interferon, and retinoids. Am J Clin Oncol 21 275-278.
182. B.D. Roebuck (1992) Dietary fat and the development of pancreatic cancer. Lipids 27 804-806.
183. B.D. Roebuck, K.J. Baumgartner and D.L. MacMillan (1993) Caloric restriction and intervention in pancreatic carcinogenesis in the rat. Cancer Res 53 46-52.
184. B.D. Roebuck, K.J. Baumgartner, C.D. Thron and D.S. Longnecker (1984) Inhibition by retinoids of the growth of azaserine-induced foci in the rat pancreas. J Natl Cancer Inst 73 233-236.
185. B.D. Roebuck, J.D. Yager Jr. and D.S. Longnecker (1981) Dietary modulation of azaserine-induced pancreatic carcinogenesis in the rat. Cancer Res 41 888-893.
186. S. Rosewicz, F. Brembeck, A. Kaiser, Z.V. Marschall and E.O. Riecken (1996) Differential growth regulation by all- trans retinoic acid is determined by protein kinase Cα in human pancreatic carcinoma cells. Endocrinology 137 3340-3347.
187. S. Rosewicz, U. Stier, F. Brembeck, A. Kaiser, C.A. Papadimitriou, W.E. Berdel, B. Wiedenmann and E.O. Riecken (1995) Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 109 1646-1660.
188. S. Rosewicz, K. Wollbergs, B. Von Lampe, H. Matthes, A. Kaiser and E.O. Riecken (1997) Retinoids inhibit adhesion to laminin in human pancreatic carcinoma cells via the α6β1-integrin receptor. Gastroenterology 112 532-542.
189. S.A. Ross (2003) Diet and DNA methylation interactions in cancer prevention. Ann NY Acad Sci 983 197-207.
190. H. Sanfey, G.B. Bulkley and J.L. Cameron (1984) The role of oxygen-derived free radicals in the pathogenesis of acute pancreatitis. Ann Surg 200 405-413.
191. M. Saruc and P.M. Pour (2003) Diabetes and its relationship to pancreatic carcinoma. Pancreas 26 381-387.
192. N. Sato, A. Maitra, N. Fukushima, N.T. van Heek, H. Matsubayashi, C.A. Iacobuzio-Donahue, C. Rosty and M. Goggins (2003) Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 63 4158-4166.
193. G. Schneider, J.T. Siveke, F. Eckel and R.M. Schmid (2005) Pancreatic cancer: basic and clinical aspects. Gastroenterology 128 1606-1625.
194. I. Schneider and F. Bucar (2005) Lipoxygenase inhibitors from natural plant sources. Part 1: Medicinal plants with inhibitory activity on arachidonate 5-lipoxygenase and 5-lipoxygenase/cyclooxygenase. Phytother Res 19 81-102.
195. M.B. Schneider, H. Matsuzaki, J. Haorah, A. Ulrich, J. Standop, X.Z. Ding, T.E. Adrian and P.M. Pour (2001) Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology 120 1263-1270.
196. H.M. Schuller (2002) Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer 2 455-463.
197. H.M. Schuller, L. Zhang, D.L. Weddle, A. Castonguay, K. Walker and M.S. Miller (2002) The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental expsure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol 128 525-532.
198. G.G. Schwartz, D. Eads, A. Rao, S.D. Cramer, M.C. Willingham, T.C. Chen, D.P. Jamieson, L. Wang, K.L. Burnstein, M.F. Holick and C. Koumenis (2004) Pancreatic cancer cells express 25-hydroxyvitamin D 1a-hydroxylase and their preliferations is inhibited by the prohormone 25-hydroxyvitamin D 3. Carcinogenesis 25 1015-1026.
199. T. Shibayama-Imazu, S. Sakairi, A. Watanabe, T. Aiuchi, S. Nakajo and K. Nakaya (2003) Vitamin K 2 selectively induced apoptosis in ovarian TYK-nu and pancreatic MIA PaCa-2 cells out of eight solid tumor cell lines through a mechanism different from geranylgeraniol. J Cancer Res Clin Oncol 129 1-11.
200. H. Shinozuka, S.L. Katyal and B. Lombardi (1978) Azaserine carcinogenesis: organ susceptibility change in rats fed a diet devoid of choline. Int J Cancer 22 36-39.
201. S.A. Silvera, T.E. Rohan, M. Jain, P.D. Terry, G.R. Howe and A.B. Miller (2005) Glycemic index, glycemic load, and pancreatic cancer risk (Canada). Cancer Causes Control 16 431-436.
202. D.T. Silverman (2001) Risk factors for pancreatic cancer: a case-control study based on direct interviews. Teratog Carcinog Mutagen 21 7-25.
203. D.T. Silverman, M. Schiffman, J. Everhart, A. Goldstein, K.D. Lillemoe, G.M. Swanson, A.G. Schwartz, L.M. Brown, R.S. Greenberg, J.B. Schoenberg, L.M. Pottern, R.N. Hoover and J.F. Fraumeni Jr. (1999) Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 80 1830-1837.
204. H.G. Skinner, D.S. Michaud, E.L. Giovannucci, F.B. Rimm, M.J. Stampfer, W.C. Willett, G.A. Colditz and C.S. Fuchs (2004) A prospective study of folate intake and the risk of pancreatic cancer in men and women. Am J Epidemiol 160 248-258.
205. R.J. Slebos, J.A. Hoppin, P.E. Tolbert, E.A. Holly, J.W. Brock, R.H. Zhang, P.M. Bracci, J. Foley, P. Stockton, L.M. McGregor, G.P. Flake and J.A. Taylor (2000) K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev 9 1223-1232.
206. P. Somasundar, A.K. Yu, L. Vona-Davis and D.W. McFadden (2003) Differential effects of leptin on cancer in vitro. J Surg Res 113 50-55.
207. H.Y. Son, A. Nishikawa, F. Furukawa, I.S. Lee, T. Ikeda, M. Miyauchi, H. Nakamura and M. Hirose (2000) Modifying effects of 4-phenylbutyl isothiocyanate on N-nitrosobis(2-oxopropyl)amine-induced tumorigenesis in hamsters. Cancer Lett 160 141-147.
208. S.K. Srivastava and S.V. Singh (2004) Cell cycle arrest, apoptosis induction and inhibition of nuclear factor-Kappa B activation in anti-proliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis 25 1701-1709.
209. J. Standop, M.B. Schneider, A. Ulrich and P.M. Pour (2001) Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 19 24-31.
210. K.R. Stayrook, J.H. McKinzie, L.H. Barbhaiya and P.L. Crowell (1998) Effects of the antitumor agent perillyl alcohol on H-Ras vs. K-Ras farnesylation and signal transduction in pancretic cells. Anticancer Res 18 823-828.
211. K.R. Stayrook, J.H. McKinzie, Y.D. Burke, Y.A. Burke and P.L. Crowell (1997) Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancretic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis 18 1655-1658.
212. R.Z. Stolzenberg-Solomon, D. Albanes, F.J. Nieto, T.J. Hartman, J.A. Tangrea, M. Rautalahti, J. Sehlub, J. Virtamo and P.R. Taylor (1999) Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers. J Natl Cancer Inst 91 535-541.
213. R.Z. Stolzenberg-Solomon, P. Pietinen, P.R. Taylor, J. Virtamo and D. Albanes (2002) Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 155 783-792.
214. S. Sumi, R.D. Beauchamp, C.M. Townsend Jr., P.M. Pour, J. Ishizuka and J.C. Thompson (1994) Lovastatin inhibits pancreatic cancer growth regardless of RAS mutation. Pancreas 9 657-661.
215. S. Sumi, R.D. Beauchamp, C.M. Townsend Jr., T. Uchida, M. Murakami, S. Rajaraman, J. Ishizuka and J.C. Thompson (1992) Inhibition of pancreatic adenocarcinoma cell growth by lovastatin. Gastroenterology 103 982-989.
216. V.S. Swaroop, S.T. Chari and J.E. Clain (2004) Severe acute pancreatitis. JAMA 291 2865-2868.
217. M. Takada, Y. Nakamura, T. Koizumi, H. Toyama, T. Kamigaki, Y. Suzuki, Y. Takeyama and Y. Kuroda (2002) Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas 25 45-48.
218. K. Takaori, R.H. Hruban, A. Maitra and N. Tanigawa (2004) Pancreatic intrapeithelial neoplasia. Pancreas 28 257-262.
219. Y. Takeda and M.J. Escribano (1991) Effects of insulin and somatostatin on the growth and the colony formation of two human pancreatic cancer cell lines. J Cancer Res Clin Oncol 117 416-420.
220. P.D. Terry, T.E. Rohan and A. Wolk (2003) Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr 77 532-543.
221. W.G. Tong, X.Z. Ding, R.C. Witt and T.E. Adrian (2002) Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway. Mol Cancer Ther 1 929-935.
222. M. Toyota, Y. Miyazaki, S. Kitamura, Y. Nagasawa, T. Kiyohara, Y. Shinomura and Y. Matsuzawa (2002) Peroxisome proliferator-activated receptor-γ reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1. Life Sci 70 1565-1575.
223. W.W. Tseng, A. Deganutti, M.N. Chen, R.E. Saxton and C.D. Liu (2002) Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and shows tumor growth in human pancreatic cancer. J Gastrointest Surg 6 838-843.
224. M. Tsujie, S. Nakamori, J. Okami, N. Hayashi, N. Hiraoka, H. Nagano, K. Dono, K. Umeshita, M. Sakon and M. Monden (2003) Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor γ/retinoid X receptor α pathway. Exp Cell Res 289 143-151.
225. M. Tsujie, S. Nakamori, J. Okami, Y. Takahashi, N. Hayashi, H. Nagano, K. Dono, K Umeshita, M. Sakon and M. Monden (2003) Growth inhibition of pancreatic cancer cells through activation of peroxisome proliferator-activated receptor γ/retinoid X receptor α pathway. Int J Oncol 23 325-331.
226. U.S. Department of Health and Human Services, Public Health Sercice, National Toxicology Program (2005) Report on Carcinogens http://ntp.niehs.nih.go/ntp/roct/to11.html Eleventh Edition. Available at
227. U.S. Food and Drug Administration (2005) Vioxx (rofecoxib) Drug Information Page http://www.fda.gov/cder/drug/infopage/vioxx/default.htm Available at
228. A.B. Ulrich, B.M. Schmied, J. Standop, M.B. Schneider and P.M. Pour (2002) Pancreatic cell lines: a review. Pancreas 24 111-120.
229. M. Valko, M. Izakovic, M. Mazur, C.J. Rhodes and J. Telser (2004) Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 266 37-56.
230. E.C. Vaquero, M. Edderkaoui, S.J. Pandol, I. Gukovsky and A.S. Gukovskaya (2004) Reactive oxygen species produced by NAD(P)H oxidase inhibit apoptosis in pancreatic cancer cells. J Biol Chem 279 34643-34654.
231. S.M. Vickers, L.K. Sampson, W. Ying and J.O. Phillips (1997) Receptor-dependent growth inhibition of human pancreatic cancer by 9- cis retinoic acid. J Gastrointest Surg 1 174-181.
232. Z. von Marschall, E.O. Riecken and S. Rosewicz (1998) Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines. Gut 43 692-698.
233. J.M. Wallace (2002) Nutritional and botanical modulation of the inflammatory cascade—eicosanoids, cyclooxygenases, and lipoxygenases—as an adjunct in cancer therapy. Integr Cancer Ther 1 7-37.
234. M. Wang, J.L. Abbruzzese, H. Friess, W.N. Hittelman, D.B. Evans, M.C. Abbruzzese, P. Chiao and D. Li (1998) DNA adducts in human pancreatic tissues and their potential role in carcinogenesis. Cancer Res 58 38-41.
235. M.J. Wargovich, C. Woods, D.M. Hollis and M.E. Zander (2001) Herbals, cancer prevention and health. J Nutr 131 3034S-3036S.
236. E. Weiderpass, T. Partanen, R. Kaaks, H. Vainio, M. Porta, T. Kauppinen, A. Ojajarvi, P. Boffetta and N. Malats (1998) Occurrence, trends and environment etiology of pancreatic cancer. Scand J Work Environ Health 24 165-174.
237. J.M. Weiss, E.L. Goode, W.C. Ladiges and C.M. Ulrich (2005) Polymorphic variation in hOGG1 and risk of cancer: al review of the functional and epidemiologic literature. Mol Carcinog 42 127-141.
238. B. Weisz, K. Giehl, M. Gana-Weisz, Y. Egozi, G. Ben-Baruch, D. Marciano, P. Gierschik and Y. Kloog (1999) A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice. Oncogene 18 2579-2588.
239. F.A. Wenger, M. Kilian, J. Ridders, P. Stahlknecht, I. Schimke, H. Guski, C.A. Jacobi and J.M. Muller (2001) Influence of antioxidative vitamins A, C and E on lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters. Prostaglandins Leukot Essent Fatty Acids 65 165-171.
240. World Cancer Research Fund and American Institute for Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective Washington, D.C.: American Institute for Cancer Research
241. R.A. Woutersen, M.J. Appel, A. van Garderen-Hoetmer and M.V. Wijnands (1999) Dietary fat and carcinogenesis. Mutat Res 443 111-127.
242. L. Xue, M. Lipkin, H. Newmark and J. Wang (1999) Influence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in mice. J Natl Cancer Inst 91 176-181.
243. L. Xue, K. Yang, H. Newmark, D. Leung and M. Lipkin (1996) Epithelial cell hyperproliferation induced in the exocrine pancreas of mice by a Western-style diet. J Natl Cancer Inst 88 1586-1590.
244. C.S. Yang, P. Maliakal and X. Meng (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42 25-54.
245. Z. Yao, Y. Okabayashi, Y. Yutsudo, T. Kitamura, W. Ogawa and M. Kasuga (2002) Role of Akt in growth and survival of PANC-1 pancreatic cancer cells. Pancreas 24 42-46.
246. T.P. Yeo, R.H. Hruban, S.D. Leach, R.E. Wilentz, T.A. Sohn, S.E. Kern, C.A. Iacobuzio-Donahue, A. Maitra, M. Goggins, M.I. Canto, R.A. Abrams, D. Laheru, E.M. Jaffee, M. Hidalgo and C.J. Yeo (2002) Pancreatic cancer. Curr Probl Cancer 26 176-275.
247. M. Yoshimoto, M. Tsutsumi, K. Iki, Y. Sasaki, T. Tsujiuchi, T. Sugimura, K. Wakabayashi and Y. Konishi (1999) Carcinogenicity of heterocyclic amines for the pancreatic duct epithelium in hamsters. Cancer Lett. 143 235-239.
248. V.R. Young (2002) 2001 W.O. Atwater Memorial Lecture and the 2001 ASNS President's Lecture: Human nutrient requirements: the challenge of the post-genome era. J Nutr 132 621-629.
249. K. Z'graggen, A.L. Warshaw, J. Werner, F. Graeme-Cook, R.E. Jimenez and C. Fernandez-del Castillo (2001) Promoting effect of a high-fat/high-protein diet in DMBA-induced ductal pancreatic cancer in rats. Ann Surg 233 688-695.
250. J. Zhang and V. Go (1996) High fat diet, lipid peroxidation, and pancreatic carcinogenesis. D. Heber, D. Kritchevsky (Eds) Dietary Fats, Lipids, Hormones, and Tumorigenesis Vol. 13 New York: Plenum Press 165-172.
251. G. Zugmaier, R. Jager, B. Grage, M.M. Gottardis, K. Havemann and C. Knabbe (1996) Growth-inhibitory effects of vitamin D analogues and retinoids on human pancreatic cancer cells. Br J Cancer 73 1341-1346.